Secondary Myelofibrosis

DBCOND0030964Hemic and Lymphatic DiseasesNeoplasms

Secondary Myelofibrosis is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.

Also known as
SMF
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10D75.81SNOMED CT119031000119101UMLSC0242006

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
37Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Secondary Myelofibrosis share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In